Yes, I understand and agree with the inventory issue. And there’s a good chance that this will help in Q2. But all that does is kick the can to Q3 and Q4. You can only fight script losses on the P&L for so long. Maybe they can fight them long enough for EU to roll out. But I don’t see any meaningful script volume overseas in ‘22.